Litigation Details for AIDS Healthcare Foundation, Inc. v. Gilead Sciences, Inc. (N.D. Cal. 2016)
✉ Email this page to a colleague
AIDS Healthcare Foundation, Inc. v. Gilead Sciences, Inc. (N.D. Cal. 2016)
Docket | ⤷ Subscribe | Date Filed | 2016-01-26 |
Court | District Court, N.D. California | Date Terminated | 2016-07-22 |
Cause | 15:1 Antitrust Litigation | Assigned To | William Haskell Alsup |
Jury Demand | Plaintiff | Referred To | |
Patents | 6,642,245; 6,703,396; 7,390,791; 7,635,704; 7,800,788; 7,803,788; 8,148,374; 8,633,219; 8,754,065; 8,981,103 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AIDS Healthcare Foundation, Inc. v. Gilead Sciences, Inc.
Biologic Drugs cited in AIDS Healthcare Foundation, Inc. v. Gilead Sciences, Inc.
Details for AIDS Healthcare Foundation, Inc. v. Gilead Sciences, Inc. (N.D. Cal. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-01-26 | 1 | Complaint | 10 U.S. Patent No. 6,642,245, entitled “Antiviral activity and resolution…years before Gilead obtained a patent on TAF, Gilead 11 had patented a similar prodrug called Tenofovir…weakness of the patents covering TAF, Gilead illegally seeks to 13 extend the period of patent exclusivity… The patents on TDF expire in 2017 and 2018. The impending expiration of the 23 TDF patents presented…was heavily reliant on the patent 24 exclusivity period of the TDF patents to prevent entry by generic | External link to document |
2016-07-06 | 108 | Order on Motion to Dismiss | 12 7,390,791 — “Prodrugs of phosphonate nucleotide Gilead … 9 patents (regardless of the patent owner) that it believes cover the … until the patent expires (if it has not already expired) or by stating that the patent is invalid or… constitutes an artificial act of patent infringement. If the patent owner initiates … PATENT PATENT OWNER | External link to document |
2016-03-21 | 34 | Motion to Dismiss | any of the patents identified in Count 1 of the Complaint including U.S. Patent No. 8,633,219.3 1n sum,…not JTI USA_as the owner of U.S. Patent No. 8,633,219 (the “‘219 Patent”). Nowhere is J T1 USA_identified…embodies a patent exhausts the patent holder’s rights and prevents the patent holder from invoking patent law…Exhibit C at p. 1. The official patent, obtained from the United States Patent and Trademark Office, clearly…alleged) that it has any. ‘219 Patent. The remaining patents set forth in the Complaint are alleged | External link to document |
2016-03-21 | 35 | Request for Judicial Notice | B - Gilead Form 10-K, # 3 Exhibit C - U.S. Patent 8,633,219)(Related document(s) 34 ) (Hoffman, Jerome | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |